Galectin Therapeutics Inc(NASDAQ:GALT) 
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is (GR-MD-02) belapectin galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharid...
Website: http://galectintherapeutics.com
Founded: 2000
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.16
H 1.32
L 1.12
C 1.32
V 257,161
10EMA 1.32
20EMA 1.32
60EMA 1.32
120EMA 1.32
250EMA 1.32